Obstructive Sleep Apnea
OSA device access, CPAP adoption, sleep-disordered breathing risk, and metabolic-care adjacency visuals.
A reusable funnel for seeing where clinically eligible patients fall out before therapy becomes sustained behavior.
Why metabolic surgery depends on selection, access, procedure fit, perioperative risk, and lifelong surveillance.
How diagnostic access, device setup, mask fit, and adherence support change the sleep apnea treatment pathway.
Use the care reality around each population to decide where education, access support, and follow-up can actually land.
Undiagnosed sleep-disordered breathing creates downstream risk across cardiovascular disease, metabolic health, daytime function, and device-adherence workflows.
Diagnosis access, home testing, PAP adherence, oral devices, cardiometabolic risk, and payer interest shape OSA value capture.
Diagnosis expansion, home testing, device adherence, cardiometabolic risk management, and payer interest reinforce the sleep apnea market.
OSA care shifts from lab-based diagnosis toward home testing, virtual setup, device coaching, and longitudinal adherence management.